These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36034740)

  • 41. Air Pollution and Corporate Green Financial Constraints: Evidence from China's Listed Companies.
    Shen Y; Lyu M; Zhu J
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Family Exit and Firms' Investment Efficiency Based on Dynamic Changes: Evidence from Chinese Family Firms.
    Wang T; Peng Q; Song H
    Comput Intell Neurosci; 2022; 2022():7572891. PubMed ID: 35958788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Pandemics on Corporate Innovation: Evidence From the Chinese Firms.
    Zhang C; Hu Y; Huang L; Huang Y
    Front Public Health; 2021; 9():780348. PubMed ID: 34805086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does corporate environmental investment impede financial performance of Chinese enterprises? The moderating role of financial constraints.
    Akbar A; Jiang X; Qureshi MA; Akbar M
    Environ Sci Pollut Res Int; 2021 Nov; 28(41):58007-58017. PubMed ID: 34101121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 impact on firm investment-Evidence from Chinese publicly listed firms.
    Jiang J; Hou J; Wang C; Liu H
    J Asian Econ; 2021 Aug; 75():101320. PubMed ID: 36567767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Marketing innovations during a global crisis: A study of China firms' response to COVID-19.
    Wang Y; Hong A; Li X; Gao J
    J Bus Res; 2020 Aug; 116():214-220. PubMed ID: 32501308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ESG performance and stock prices: evidence from the COVID-19 outbreak in China.
    Li Z; Feng L; Pan Z; Sohail HM
    Humanit Soc Sci Commun; 2022; 9(1):242. PubMed ID: 35874283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19, ESG investing, and the resilience of more sustainable stocks: Evidence from European firms.
    Cardillo G; Bendinelli E; Torluccio G
    Bus Strategy Environ; 2022 Jun; ():. PubMed ID: 35942337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of COVID-19 related government response stringency and support policies: Evidence from European firms.
    Janzen B; Radulescu D
    Econ Anal Policy; 2022 Dec; 76():129-145. PubMed ID: 35959486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stock market reaction to COVID-19: Evidence from U.S. Firms' International exposure.
    Au Yong HH; Laing E
    Int Rev Financ Anal; 2021 Jul; 76():101656. PubMed ID: 36569818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Internationalization and the capital structure of firms in emerging markets: Evidence from Latin America before and after the financial crisis.
    Melgarejo Duran M; Stephen SA
    Res Int Bus Finance; 2020 Dec; 54():101288. PubMed ID: 34173404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How does firms' broadband adoption affect regional TFP in Italy?
    Giannini M; Martini B; Fiorelli C
    Econ Polit (Bologna); 2022 Jun; ():1-26. PubMed ID: 35730018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The management of Industry 4.0 technologies and environmental assets for optimal performance of industrial firms in Malaysia.
    Ali Q; Parveen S; Yaacob H; Zaini Z
    Environ Sci Pollut Res Int; 2022 Jul; 29(35):52964-52983. PubMed ID: 35277822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Firms' challenges and social responsibilities during Covid-19: A Twitter analysis.
    Patuelli A; Caldarelli G; Lattanzi N; Saracco F
    PLoS One; 2021; 16(7):e0254748. PubMed ID: 34314432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brand equity and the Covid-19 stock market crash: Evidence from U.S. listed firms.
    Huang Y; Yang S; Zhu Q
    Financ Res Lett; 2021 Nov; 43():101941. PubMed ID: 36568952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are environmentally friendly firms more vulnerable during the COVID-19 pandemic?
    Zhang D; Fang Y
    J Clean Prod; 2022 Jun; 355():131781. PubMed ID: 35466288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thermodynamics of firms' growth.
    Zambrano E; Hernando A; Fernández Bariviera A; Hernando R; Plastino A
    J R Soc Interface; 2015 Nov; 12(112):. PubMed ID: 26510828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impacts of Covid-19 on Norwegian salmon exports: A firm-level analysis.
    Straume HM; Asche F; Oglend A; Abrahamsen EB; Birkenbach AM; Langguth J; Lanquepin G; Roll KH
    Aquaculture; 2022 Dec; 561():738678. PubMed ID: 35937035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reacting to the economic fallout of the COVID-19: Evidence on debt exposure and asset management of Italian firms.
    Ferragina AM; Iandolo S
    Econ Anal Policy; 2022 Sep; 75():530-547. PubMed ID: 35754528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Digitalization and resilience during the COVID-19 pandemic.
    Abidi N; El Herradi M; Sakha S
    Telecomm Policy; 2023 May; 47(4):102522. PubMed ID: 37051116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.